Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Adverse event reports following vaccination for Lyme disease: December 1998-July 2000.

Lathrop SL, Ball R, Haber P, Mootrey GT, Braun MM, Shadomy SV, Ellenberg SS, Chen RT, Hayes EB.

Vaccine. 2002 Feb 22;20(11-12):1603-8.

PMID:
11858868
2.

Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.

Haber P, Moro PL, Lewis P, Woo EJ, Jankosky C, Cano M.

Vaccine. 2016 May 11;34(22):2507-12. doi: 10.1016/j.vaccine.2016.03.048. Epub 2016 Mar 23. Review.

3.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
4.

Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ; Anthrax Vaccine Export Committee.

Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):189-202. Review.

PMID:
12051118
5.

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.

Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT.

Pediatr Infect Dis J. 2004 Apr;23(4):287-94. Review.

PMID:
15071280
6.

Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, Ward BJ, West DJ.

Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):825-40. Review.

PMID:
15386719
7.

Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.

Chang S, Ball R, Braun MM.

Vaccine. 2008 May 2;26(19):2428-32. doi: 10.1016/j.vaccine.2008.02.052. Epub 2008 Mar 17. Review.

PMID:
18406499
8.

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).

Shimabukuro TT, Nguyen M, Martin D, DeStefano F.

Vaccine. 2015 Aug 26;33(36):4398-405. doi: 10.1016/j.vaccine.2015.07.035. Epub 2015 Jul 22. Review.

9.

Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.

Asatryan A, Pool V, Chen RT, Kohl KS, Davis RL, Iskander JK; VAERS team.

Vaccine. 2008 Feb 26;26(9):1166-72. doi: 10.1016/j.vaccine.2007.12.049. Epub 2008 Jan 22. Review.

PMID:
18255204
10.

Rotavirus live, oral, pentavalent vaccine.

Tom-Revzon C.

Clin Ther. 2007 Dec;29(12):2724-37. doi: 10.1016/j.clinthera.2007.12.018. Review.

PMID:
18201590
11.

Vaccine safety.

Jacobson RM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):589-603. Review.

PMID:
14753382
12.

Reporting rates of yellow fever vaccine 17D or 17DD-associated serious adverse events in pharmacovigilance data bases: systematic review.

Thomas RE, Lorenzetti DL, Spragins W, Jackson D, Williamson T.

Curr Drug Saf. 2011 Jul;6(3):145-54. Review.

PMID:
22122389
13.

The prevention of Lyme disease with vaccine.

Poland GA, Jacobson RM.

Vaccine. 2001 Mar 21;19(17-19):2303-8. Review.

PMID:
11257352
14.

Immediate allergic reactions after vaccinations--a post-marketing surveillance review.

Zent O, Arras-Reiter C, Broeker M, Hennig R.

Eur J Pediatr. 2002 Jan;161(1):21-5. Review.

PMID:
11808876
16.

Data mining in the US using the Vaccine Adverse Event Reporting System.

Iskander J, Pool V, Zhou W, English-Bullard R; VAERS Team.

Drug Saf. 2006;29(5):375-84. Review.

PMID:
16689554
17.

The rise and fall of the lyme disease vaccines: a cautionary tale for risk interventions in American medicine and public health.

Aronowitz RA.

Milbank Q. 2012 Jun;90(2):250-77. doi: 10.1111/j.1468-0009.2012.00663.x. Review.

Supplemental Content

Support Center